Electronic Quitline Referral With Enhanced Academic Detailing for the Promotion of Smoking Cessation

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

9133 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-06-20

Study Completion Date

2026-02-22

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This phase IV clinical trial determines the impact of implementing a Quitline electronic (e)Referral system with an enhanced academic detailing implementation strategy on Quitline reach, tobacco cessation assistance and self-reported quit rates among patients in community health centers. It also examines the cost-effectiveness of Quitline eReferrals both with and without enhanced academic detailing. If this implementation strategy is effective, this strategy could be used to increase tobacco cessation treatment through the collaboration between state Quitlines and community health centers that serve large numbers of socioeconomically disadvantaged patients who use tobacco.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Strategies to Connect Patients at Federally Qualified Health Clinics With Evidence Based Tobacco Cessation Treatment

NCT03900767

Current Smoker Tobacco Smoking Tobacco Use

ACTIVE_NOT_RECRUITING NA

Efficacy and Cost of State Quitline Policies

NCT00366977

Smoking Cessation Tobacco Use Cessation Cost-effectiveness

COMPLETED PHASE3

Computer-Assisted Stop-Smoking Program in Helping Doctors Counsel Patients Who Smoke Cigarettes

NCT00865553

Tobacco Use Disorder

UNKNOWN PHASE2

Effectiveness of a Web-Assisted Quitline for Smokeless Tobacco Users

NCT00820495

Tobacco Use Disorder

COMPLETED PHASE2

Testing a Novel Smartphone Application for Smoking Cessation With the Oklahoma Helpline

NCT05539209

Smoking Cessation

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

PRIMARY OBJECTIVES:

I. Implement a Quitline electronic (e)Referral system with enhanced academic detailing (AD) (intervention; n=10 community health centers \[CHCs\]) and without enhanced AD (comparison; n=10 CHCs) to compare rates of eReferral offers, eReferral acceptance, Quitline enrollment, orders for tobacco cessation medication, and receipt of in-clinic counseling among patients identified as currently using tobacco.

II. Assess the effectiveness of implementing a Quitline eReferral system with enhanced AD (intervention) versus without enhanced AD (comparison) on self-reported tobacco quit rates among all patients identified as current persons using tobacco using electronic health record (EHR) data.

III. Estimate the total annual costs and incremental cost-effectiveness of a Quitline eReferral system, with and without enhanced AD.

OUTLINE: Clinics are randomized to 1 of 2 arms.

ARM I: Clinics are notified via email that the eReferral system is available with a link to an online publication that includes an overview of Quitline services, information on Quitline effectiveness, and a detailed eReferral workflow with corresponding electronic health record (EHR) screenshots, including how to identify eligible patients, create an eReferral, and access Quitline follow-up data in the EHR. Clinics also gain access to technological assistance, as needed.

ARM II: Clinics receive standard online materials and access to remote technological assistance as in Arm I. Clinics also receive group training of clinic staff prior to activation of the Quitline eReferral system and 12 months post-activation, follow-up booster sessions and monthly performance audit and feedback.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tobacco-Related Carcinoma Smoking &Amp; Tobacco Cessation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arm I (Quitline eReferral)

Clinics are notified via email that the Quitline eReferral system is available with a link to an online publication that includes an overview of Quitline services, information on Quitline effectiveness, and a detailed eReferral workflow with corresponding EHR screenshots, including how to identify eligible patients, create an eReferral, and access Quitline follow-up data in the EHR. Clinics also gain access to technological assistance, as needed.

Group Type ACTIVE_COMPARATOR

Informational Intervention

Intervention Type OTHER

Receive overview of Quitline services and use of Quitline eReferral via online materials

ARM II (Quitline eReferral plus enhanced AD)

Clinics receive standard online materials access to remote technological assistance as in Arm I. Clinics also receive group training of clinic staff prior to activation of the eReferral system and 12 months post-activation, follow-up booster sessions and monthly performance audit and feedback.

Group Type EXPERIMENTAL

Enhanced Academic Detailing

Intervention Type BEHAVIORAL

* Group training of clinic staff prior to activation of the eReferral system and 12 months post-activation
* Follow-up booster sessions
* Monthly performance audit and feedback

Informational Intervention

Intervention Type OTHER

Receive overview of Quitline services and use of Quitline eReferral via online materials

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Enhanced Academic Detailing

* Group training of clinic staff prior to activation of the eReferral system and 12 months post-activation
* Follow-up booster sessions
* Monthly performance audit and feedback

Intervention Type BEHAVIORAL

Informational Intervention

Receive overview of Quitline services and use of Quitline eReferral via online materials

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

EAD

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* In Oregon
* On the OCHIN Epic EHR for \>= 1 year
* Willing to be randomized to the intervention or comparison condition
* Willing to recruit a provider to serve as a clinic champion (to share monthly performance audit and feedback at all-staff meetings, determine desired content of booster sessions with clinic team members, and complete a survey at the completion of the intervention period) and a clinic manager to coordinate training and booster sessions

* Adult patients (\>= 18 years of age)
* Identified as current tobacco users during \>= 1 ambulatory and/or telehealth visit to one of the eligible study clinics over the 24-month study period

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes